| scholarly article | Q13442814 |
| P50 | author | Shellie Ellis | Q60663757 |
| P2093 | author name string | Ronald C Chen | |
| James L Mohler | |||
| Paul A Godley | |||
| William R Carpenter | |||
| Jeannette T Bensen | |||
| Merle Mishel | |||
| Bonny Blackard | |||
| P2860 | cites work | Trends and racial differences in the use of androgen deprivation therapy for metastatic prostate cancer | Q37426733 |
| Mistrust of health care organizations is associated with underutilization of health services | Q37485248 | ||
| NCCN Practice Guidelines for Prostate Cancer. | Q39558609 | ||
| Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience | Q43544429 | ||
| Racial and ethnic variation in health resource use and cost for prostate cancer | Q44202058 | ||
| Reimbursement policy and androgen-deprivation therapy for prostate cancer | Q46147188 | ||
| Prostate cancer treatment for economically disadvantaged men: a comparison of county hospitals and private providers | Q46701216 | ||
| Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. | Q46733585 | ||
| The North Carolina-Louisiana Prostate Cancer Project (PCaP): methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomes | Q46950336 | ||
| Symbiotic relationships of quality of life, health services research and other health research. | Q53657256 | ||
| Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients | Q73225578 | ||
| Variations in quality of care for men with early-stage prostate cancer | Q81724075 | ||
| Prostate cancer. NCCN clinical practice guidelines in oncology | Q84610510 | ||
| Intermittent versus continuous androgen suppression for prostatic cancer | Q24243575 | ||
| Association of insurance with cancer care utilization and outcomes | Q28261934 | ||
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States). | Q30586030 | ||
| Demographics, insurance coverage, and utilization of medical services in newly diagnosed prostate cancer: data from caPSURE. | Q30984799 | ||
| Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1) | Q33559123 | ||
| Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap | Q33606053 | ||
| Time trends and local variation in primary treatment of localized prostate cancer | Q33710948 | ||
| 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial | Q34341758 | ||
| Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist | Q35754343 | ||
| Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007 | Q36163573 | ||
| Characteristics of urologists predict the use of androgen deprivation therapy for prostate cancer | Q36303686 | ||
| Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? | Q36503071 | ||
| Racial segregation and disparities in health care delivery: conceptual model and empirical assessment. | Q37335752 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 2282-2290 | |
| P577 | publication date | 2013-04-10 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina | |
| P478 | volume | 119 |
| Q34288005 | Are HIV-infected men vulnerable to prostate cancer treatment disparities? |
| Q40824861 | Association between Types of Chronic Conditions and Cancer Stage at Diagnosis among Elderly Medicare Beneficiaries with Prostate Cancer |
| Q91899590 | Disparities in Surgical Access: A Systematic Literature Review, Conceptual Model, and Evidence Map |
| Q33761801 | Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer |
| Q46174820 | Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer. |
| Q35828702 | HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy |
| Q38659673 | Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer |
| Q34542337 | Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between White (non-Hispanic) and African-American groups |
| Q36062411 | Racial Differences in Diffusion of Intensity-Modulated Radiation Therapy for Localized Prostate Cancer |
| Q36655971 | Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database |
| Q86574950 | Racial disparities in prostate cancer care: is adherence to National Comprehensive Cancer Network guidelines good enough for our patients? |
| Q40762402 | Racial/ethnic differences in the relative risk of receipt of specific treatment among men with prostate cancer |
| Q34765233 | Reclassification rates are higher among African American men than Caucasians on active surveillance |
| Q41294217 | Treatment decisional regret among men with prostate cancer: Racial differences and influential factors in the North Carolina Health Access and Prostate Cancer Treatment Project (HCaP-NC). |
| Q44670933 | Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups |
Search more.